Ionizing radiation induces alterations in cellular proliferation and c-myc, c-jun and c-fos protein expression in

G M Calaf1, T K Hei

  • 1Center for Radiological Research, College of Physicians and Surgeons of Columbia University, New York, NY, USA. gmc24@columbia.edu

Insights

Ionizing radiation affects oncogene expression differently in breast epithelial cells. While radiation decreased c-myc, c-jun, and c-fos in normal cells, it increased their expression in carcinogen-exposed and tumorigenic cells, indicating a role in breast cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer pathogenesis is linked to the identification of critical genes.
  • Nuclear proto-oncogenes like c-myc, c-jun, and c-fos are involved in cellular proliferation.
  • c-myc is frequently over-expressed in breast cancer.

Purpose of the Study:

  • To determine the functional role of oncogenes in radiation-induced transformation of human breast epithelial cells.
  • To investigate the impact of ionizing radiation on specific oncogene expression in different cellular contexts.

Main Methods:

  • Utilized the MCF-10F cell line and its derivatives, including benzo(a)pyrene (BP)-treated and c-Ha-ras-transfected clones.
  • Exposed cells to a single 3 Gy dose of gamma radiation.
  • Analyzed protein expression of c-myc, c-jun, and c-fos using Western immunoblot assays.

Main Results:

  • Gamma radiation decreased oncoprotein expression in MCF-10F cells (23-80%) and non-tumorigenic BP1 cells (50-100%).
  • In contrast, radiation increased c-myc, c-jun, and c-fos expression in tumorigenic BP1-E cells (68-80%), c-Ha-ras-3 Gy cells (45-120%), and BP1-Tras-3 Gy cells (>120%).

Conclusions:

  • The MCF-10F model effectively demonstrates differential regulation of oncogene expression by ionizing radiation.
  • Radiation's effect on c-myc, c-jun, and c-fos expression varies based on cellular transformation status, offering insights into breast cancer development.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...